Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03327051 · ClinicalTrials.gov registry record · Phase 4
Gastric Acid Suppression and Probiotic Colonization
A Phase 4 study of Probiotics, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 39
- Enrollment target
- 1
- Study location
NCT03327051 is a Phase 4 study of Probiotics that has completed, run by Stanford University. The registered enrollment target is 39 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03327051, a Phase 4 study of Probiotics, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
Probiotics are over-the-counter dietary products with microorganisms that are generally consumed for health benefit. However, the durability of these microorganisms is unclear, particularly when they pass through the highly acidic environment of the stomach. We will test the colonization of these microorganisms among individuals who consume probiotics with and without acid suppression therapy.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Omeprazole
- DIETARY_SUPPLEMENT VSL #3
Study Locations (1)
California
- Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2018-03-20 |
| Est. Completion | 2018-12-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03327051
The ClinicalTrials.gov registry entry for NCT03327051 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Probiotics appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT03327051 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03327051 about?
NCT03327051 is a clinical study titled "Gastric Acid Suppression and Probiotic Colonization". Probiotics are over-the-counter dietary products with microorganisms that are generally consumed for health benefit. However, the durability of these microorganisms is unclear, particularly when they pass through the highly acidic environment of the stomach. We will test the colonization of these mi...
What is the current status of trial NCT03327051?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 39 participants. The study started on 2018-03-20. Estimated completion is 2018-12-30.
What conditions does trial NCT03327051 study?
This clinical trial studies the following conditions: Probiotics.
What interventions are being tested in trial NCT03327051?
The interventions under investigation include: Placebo (DRUG), Omeprazole (DRUG), VSL #3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03327051?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03327051 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Probiotics
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.